CRISPR mouse models show EML4-ALK fusion variants alter drug response, suggesting a need for variant-specific treatment.

Lonza says it provides services ranging from early phase development to full-scale commercial manufacturing at the St. Petersburg site.

RION officials say the company developed a proprietary biomanufacturing platform enabling scaled production of platelet-derived exosomes. This platform allows for the advancement of RION’s pipeline of ...

Researchers say findings could lead to breakthroughs in tissue repair and regenerative medicine, as well as advanced medical ...

PacBio enters the high-throughput carrier screening market with a standalone HiFi sequencing assay for challenging genes.

Pfizer has agreed to acquire Metsera for up to $7.3 billion, the companies said, in a deal that returns the pharma giant to the obesity and metabolic drug space from which it retreated this past ...

HIV’s Tat protein blocks autophagy in macrophages, letting Mtb thrive. This may explain why HIV patients face higher TB risk even on ART.

If future studies confirm the rescued receptors work normally, the study offers a new roadmap for rare disease drug development.

Machine learning identifies disease-specific signatures in organoids derived from schizophrenia and bipolar disorder patients.

Antibody purification evolves with diverse formats, driving tailored chromatography solutions for efficiency, scalability, ...

A mutation causes a defect in the production of exosomes, which has been shown to drive the progression of Alzheimer's ...

Researchers say findings underscore the potential importance of oral health interventions for prevention of pancreatic cancer ...